Search
 
Tilt Table Testing

Tilt table testing is used to evaluate syncope in younger, apparently healthy patients and, when cardiac and other tests have not provided a diagnosis, in elderly patients. Tilt table testing produces maximal venous pooling, which can trigger vasovagal (neurocardiogenic) syncope and reproduce the symptoms and signs that accompany it (nausea, light-headedness, pallor, hypotension, bradycardia).

After an overnight fast, a patient is placed on a motorized table with a foot board at one end and is held in place by a single strap over the stomach; an IV line is inserted. After the patient remains supine for 15 min, the table is tilted nearly upright to 60 to 80° for 45 min. If vasovagal symptoms develop, vasovagal syncope is confirmed. If they do not occur, a drug (eg, isoproterenolSome Trade Names
ISUPREL
Click for Drug Monograph
) may be given to induce them. Sensitivity varies from 30 to 80% depending on the protocol used. The false-positive rate is 10 to 15%.

With vasovagal syncope, heart rate and BP usually decrease. Some patients have only a decrease in heart rate (cardioinhibitory); others have only a decrease in BP (vasodepressor). Other responses include a gradual decrease in systolic and diastolic BP with little change in heart rate (dysautonomic pattern), significant increase in heart rate (> 30 beats/min) with little change in BP (postural orthostatic tachycardia syndrome), and report of syncope with no hemodynamic changes (psychogenic syncope).

Relative contraindications include severe aortic or mitral stenosis, hypertrophic cardiomyopathy, and severe coronary artery disease (CAD). In particular, isoproterenolSome Trade Names
ISUPREL
Click for Drug Monograph
should not be used in patients with hypertrophic cardiomyopathy or severe CAD.

Last full review/revision May 2009 by Michael J. Shea, MD

Content last modified May 2009

Back to Top

Previous: Stress Testing

Next: Overview of Hypertension

Audio
Figures
Photographs
Tables
Videos

Copyright     © 2010-2011 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use